Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating hysteromyoma and preparation method of drug

A technology of uterine fibroids and drugs, which is applied in the field of drugs for the treatment of uterine fibroids and its preparation, and can solve problems such as slow recovery, long operation time, and heavy physical burden

Inactive Publication Date: 2018-09-28
张春枝
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them: A. Western medicine treatment, which uses sex hormone drugs in clinical practice to forcibly reduce the androgen level. Although it can inhibit the growth of fibroids in the short term, long-term application of hormone therapy in large quantities will burden the body and easily cause substance metabolism and water-salt metabolism. Disturbance, leading to aggravation of endocrine disorders, long-term use has great side effects, and severe cases can lead to pathological changes
B. Traditional laparotomy: "One size fits all" refers to making an incision in the patient's abdomen, opening the uterus, and removing the fibroids. Some even need to remove the entire uterus, and then suture the wound. The operation time is long, the recovery is slow, and serious It will affect normal work, and the postoperative abdomen will leave scars, which will affect the appearance, and may cause complications such as abdominal infection and pelvic adhesions. In severe cases, it will lead to infertility, and it does not improve the growth environment of fibroids, and it is very easy to relapse
C. Minimally invasive surgery, interventional surgery: The so-called minimally invasive surgery is actually a kind of surgery, but the superficial skin wound is relatively small, but the abdominal cavity still needs to be operated, and the doctor cannot touch the uterus, making some small fibroids slip through the net The fish will leave hidden dangers in the future, the recurrence rate is extremely high, and it will cause trauma to the uterus again
[0003] At present, there are very few Chinese patent medicines for treating uterine fibroids on the market, which cannot meet the needs of the society. On the other hand, the curative effect of these old medicines is still not particularly satisfactory, and traditional Chinese patent medicines with further improvement in curative effect need to be developed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1, a kind of medicine for the treatment of uterine fibroids is refined from the following raw materials in parts by weight, 20 parts of Glauber's salt, 15 parts of cassia twig, 25 parts of seaweed, 25 parts of salvia miltiorrhiza, 15 parts of Trichosanthes trichosanthes, orange pit 25 copies, hawthorn 25 copies, Achyranthes knee 25 parts, 25 parts of dried blood, 25 parts of fritillaria, 25 parts of white mustard seed, 15 parts of trigonum, 25 parts of coix seed, 20 parts of Prunella vulgaris, 25 parts of peach kernel, 25 parts of southern star, 25 parts of red peony root, 30 parts of licorice, Raw dandelion 20 parts, 25 parts of Wulingzhi, 25 parts of frankincense, 25 parts of myrrh, 20 parts of rehmannia glutinosa, and 20 parts of Bupleurum.

[0025] The dosage form of the above-mentioned medicine for treating uterine fibroids is a pill.

[0026] Described medicine for the treatment of uterine fibroids and preparation method thereof, its specific proce...

Embodiment 2

[0031] Embodiment 2, a kind of medicine for the treatment of uterine fibroids, by taking parts by weight as a unit, the crude drug that makes its active ingredient is: Glauber's salt 15 parts, cassia twig 10 parts, seaweed 20 parts, salvia miltiorrhiza 15 parts, trichosanthes trichosanthes 10 parts share, orange pit 20 copies, hawthorn 20 copies, Achyranthes knee 15 parts, 20 parts of dried blood, 20 parts of Fritillaria, 15 parts of white mustard seed, 10 parts of trigonum, 20 parts of coix seed, 15 parts of Prunella vulgaris, 20 parts of peach kernel, 20 parts of southern star, 15 parts of red peony root, 20 parts of licorice, Raw dandelion 10 parts, 15 parts of Wulingzhi, 20 parts of frankincense, 20 parts of myrrh, 15 parts of rehmannia glutinosa, and 15 parts of Bupleurum.

Embodiment 3

[0032] Embodiment 3, a kind of medicine for the treatment of uterine fibroids, by taking parts by weight as a unit, the raw material drug that makes its active ingredient is: Glauber's salt 25 parts, cassia twig 20 parts, seaweed 30 parts, salvia miltiorrhiza 35 parts, trichosanthes trichosanthes 20 parts share, orange pit 30 servings, hawthorn 30 copies, Achyranthes knee 35 parts, 30 parts of dried blood, 30 parts of Fritillaria, 35 parts of white mustard seed, 20 parts of trigonum, 30 parts of coix seed, 25 parts of Prunella vulgaris, 30 parts of peach kernel, 30 parts of southern star, 35 parts of red peony root, 40 parts of licorice, Raw dandelion 30 parts, 35 parts of Wulingzhi, 30 parts of frankincense, 30 parts of myrrh, 25 parts of rehmannia glutinosa, and 25 parts of Bupleurum.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a drug for treating hysteromyoma. The drug is made by preparing the following crude drugs into effective components of the drug in parts by weight: natrii sulfas, ramulus cinnamomi, sargassum, radix salviae miltiorrhizae, fructus trichosanthis, semen citri reticulatae, fructus crataegi, radix achyranthis bidentatae, resina draconis, bulbus fritillariae cirrhosae, semen brassicae, rhizoma sparganii, semen coicis, spica prunellae, semen persicae, rhizoma arisaematis, radix paeoniae rubra, licorice root, raw pollen typhae, trogopterus dung, frankincense, myrrh, radix rehmanniae and radix bupleuri. The drug for treating hysteromyoma, provided by the invention, has a good therapeutic effect without toxic and side effects, can fundamentally treat symptoms including qi stagnation and blood stasis, phlegm-dampness stagnation, dampness-heat stagnation, kidney deficiency and blood stasis, and the like, can improve endocrine of an organism of a patient, strength the physique of the patient with hysteromyoma, has great benefits to prevent relapse and metastasis of the hysteromyoma, has a very good effect through clinical practice, and is convenient to take and liable inpopularization.

Description

1. Technical field: [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a medicine for treating uterine fibroids and a preparation method thereof. 2. Background technology: [0002] Uterine fibroids are the most common benign tumors in female reproductive organs, and they are also one of the most common tumors in the human body. Uterine fibroids belong to the disease of "accumulation of lumps in the abdomen", which is mostly caused by the stagnation of Qi and blood and obstruction of the cell veins. There are 320 million people in the world, and nearly 1.5 million women in China have their uterus removed every year due to uterine fibroids; the current treatment methods for uterine fibroids include western medicine, traditional laparotomy, minimally invasive surgery, and interventional surgery. Among them: A. Western medicine treatment, which uses sex hormone drugs in clinical practice to forcibly reduce the androgen level...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/902A61P35/00A61K33/04A61K35/24
CPCA61K33/04A61K35/24A61K36/02A61K36/21A61K36/233A61K36/31A61K36/324A61K36/328A61K36/428A61K36/484A61K36/536A61K36/537A61K36/54A61K36/65A61K36/71A61K36/734A61K36/736A61K36/752A61K36/804A61K36/88A61K36/8884A61K36/889A61K36/896A61K36/8966A61K36/8994A61K36/902A61P35/00A61K2300/00
Inventor 张春枝
Owner 张春枝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products